<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 51 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page50.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=51">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 51 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 51</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=51"><img src="../thumb/51.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>20 / 2020-04                                                 Central Nervous System - 1.4.5 / 1.4.6 / 1.4.7
   Side-effects: CNS effs., headache, dizzin., dry mouth, GI disturbs.,   (S5) CAPS, A40/1.2/0032, 0033, 0034  Indications: DSM IV criteria defin.depress., relapse & recurr.prevent.
   abnorm. ejaculat./orgasm, sweat., asthen., ecchymos., weight/ser.  706399-001: 37,5 mg, 30, R198,23  follow.satisfact.respons.
   cholester. chang., hyperaesthes., decr.libido, trem., paraesthes., anx.,   706402-001: 75 mg, 30, R260,41  (S5) SR TABS, 34/1.2/0266
   depersonalisat., somnol., emot. labilit., hyperton., trismus, vertigo,   706404-001: 150 mg, 30, R443,25  704070-001: 150 mg, 60, R464,93
   abnorm.vis./ accommodat., mydrias., tinnit., hypertens., palpitat.,   Dosage: Admin.with food. Swallow whole. If ther. long.than 6 wks.  Dosage: Ther.to be init.by physic.exper.in depress. treatm. Swallow
   tachycard., postur.hypotens., vasodilat., oed., pharyngit., yawn., rhinit.,   taper.over period of at least 2 wks.depend.on dos./durat.& indiv.pt  whole. Poss. incr.expos. if taken with food.
   bronchit., dyspn., skin reacts., myalg., arthralg., impot., urin.freq./ re-  Usual recomm.dos: 75 mg once dly. Incr.to 150 mg once dly. aft.  Adults: Init.150 mg dly.as sngl.dly.dos. Full antidepress.eff.poss.not
   tent., imp.urinat., chills, migraine, abdom./back/ neck & chest pain.,   sever.wks.if further clinic. improvem.reqd. If necess.dos.can be fur-  evid.until aft.sev.wks. Dos.may be incr.to max.300 mg/day in pts not
   mania/hypoman.activat., anorex.  ther incr. to 225 mg once dly. Dos.increm.should be made at interv.  respond.adeq.to 150 mg dly. Max.sngl.dos.not to exceed 150 mg. Dos.
   Special precautions: Advis.dr.of pregn./plan pregn., observ.for   of approxim.2 wks.or more but not less than 4 days. Dos.for depress.  great.than 150 mg to be taken as twice dly.dos.with interv.of at least
   clinic.worsen./suic.esp.init.& dur.dos. chang., monit.as for psych.&   pts.may be furth. incr. to 375 mg once dly.if need. Then grad. reduc.   8 hrs. Maint: 300 mg /day shown to be effic.for treatm.of up to 1 yr.
   non-psych. disord.pts., consid.chang.therap.regim./discont.if sev.   dos.consistent.with respons.&tol.  (S5) XL EXTEND.REL.TABS, 41/1.2/0371, 0372
   suicid.impuls.sympts.pres./when such sympts. are abrupt in onset/  Contraindications: Safety & effic.in childr.und.18 yrs. not est., safety   711008-001: 150 mg, 30, R431,27
   not part of pres.sympts., grad. withdr., concom.warfar./haloperidol,   dur.pregn.& lactat.not est., concom.MAOI/within 14 days of MAOI   711009-001: 300 mg, 30, R431,27
                                discont./init.MAOI 7 days aft.discont. venlafaxine.
   avoid concom. alcoh., elderly/hepat.dysfunct.with concom. cimeti-  Dosage: Ther.to be init.by physic.exper.in depress. treatm. Swallow
   dine, other concom.meds.with serotonerg. effs., ren./hepat.impairm.,   Side effects: CNS effs.incl.convuls., GI disturbs., abnorm.ejaculat./  whole. Interv. of at least 24 hrs.betw. success. dos.
                                orgasm, sweat., asthen., ecchymos., muc.membr.bleed., prolong.
   re-assess longt. treatm.per., hostility/suic.ideat.& self-harm. in childr.,   Adults: Init.150 mg dly.as sngl.dly.dos.in the morn. Dos.may be incr.to
   suic.risk esp.in depress., seiz.hist., discont. ther.if seiz.devel., alert dr.if   bleed. time, thrombocytopen., bld.dyscras., ser. cholesterol chang-  max.300 mg once dly. in pts not respond.adeq.to 150 mg dly. When
                                es, weight gain/loss, hyponatraem., hepatit., SIADH, incr.prolact.,
   allerg.S&S, monit. BP of pts.at risk, mania hist., signific.weight loss   neuropsych. disords., depersonalisat., NMS, serotonerg. syndr.,   switch. from SR tabs.admin. same tot.dly.dos. when poss.
   in underweight pts., drug abuse hist., dis./ condits. aff.haemodynam.  extrapyramid.reacts., manic react., accommodat.abnorm., mydrias.,   Contraindications: Seiz.disords./hist.therof, concom. treatm. with
   respons./metab., rec.MI/ unstab. heart dis.hist., underly.condits.  vis. disturbs., taste pervers., tinnit., vasodilat., hypertens., palpitat.,   any other prep cont. bupropion, abrupt discont.of alcoh./sedat., curr./
   poss. comprom. by incr.heart rate, liv.cirrhos., excret.in breast milk.  post.hypotens., QT prolongat., ventric.tachycard./fibrillat., yawn.,   prev. bulimia/ anorex. nervosa diagn., MAOI, sev. liv.dis.(Child-Pugh
   Drug interactions: Sev.reacts.incl.death with init. ther.soon aft.  pharyngit., rhinit., bronchit., pulm.eosinophil., rash, prurit., alopec.,   grad.B/ C range 7-13), safety in pregn. & lactat.not est., safety & ef-
   MAOI discont./init.of MAOI soon aft. venlafaxine discont., anti-  Stev.John.syndr., erythem. multiforme, arthralg., myalg., rhabdomy-  fic.in pts.und. 18 yrs.not est., mod.to sev.hepat.cirrhos.
   coag.eff.of warfar. potent., poss.incr.motor/ment.skills impairm.  olys., urin. freq., anorgasm., erect.dysfunct., imp. urinat., menorrhag.,   Side effects: Insomn., seiz., hypersens.reacts. incl. angioed./dyspn./
   with ethanol, decr.clear.& incr.in AUC & C max.of haloperidol, decr.in   urin.retent., abdom/back/ neck & chest pain, chills, anaphylax., pho-  bronchosp./anaphylact. shock, arthralg., myalg., fev., rash, ser.sickn.,
   AUC & C max.of indinavir, AUC of risperidone incr., first-pass metab.  tosens., discont.effs.  weight loss, anorex., vis./bld.gluc./taste disturbs., agitat., anx., psych.
   inhib.with cimetidine.       Special precautions: Suic.risk esp.in depress., observ.for clinic.  disords.incl. hallucinat./ depersonalisat. & paranoid ideat., headache,
   VENLAFAXINE XR ADCO, AI Pharm Ltd [P/S]  worsen./suic.esp.init.& dur.dos. chang., monit.as for psych.& non-  tremor, dizzin., conc.disturb., CNS effs. incl.dyston./memory impairm./
                                                              parkinsonism/ incoordinat./ syncope, tinnit., tachycard., palpitat., incr.
   Venlafaxine HCl.equiv.to venlafaxine.  psych.disord. pts., consid.chang.therapeut.regim/discont.if sev.sui-  BP, flush., vasodilat., post. hypotens., GI disturbs., elev.liv.enzym.,
                                cid.impuls. sympts.pres./when such sympts. are abrupt in onset/ not
   Indications: Depress.incl.depress.with anx., prevent. of relapse epi-  part of pres. sympts., monit.pt. dur.grad.withdr., other concom. meds.  jaund., hepatit., prurit., sweat., erythem.multiforme/ Stev.Johns.
   sod.of depress.in pts. respond. to init.6-8 wks.treatm., recurr.prev.in   with serotonerg.effs., concom. alcoh.not advis., elderly, neonates ex-  syndr., twitch., urin.freq./retent., fev., asthen., chest pain.
   pts. respond.to 6 mnths relapse prevent., gen.anx. disord., soc.anx.  pos.late in 3  trimest. develop.complicat.req.resp.support/ prolong   Special precautions: Excret. in breast milk, incr. adverse eff.risk if
                                      rd
   disord.where treatm.effic.not demonstrat. for more than 12 wks.  hospitalisat., excret.in breast milk, ren./ liv. impairm., re-assess long   tabs.are crush./cut/chew., avoid bedt. dos.to reduce insomn.provid.
   (S5) CAPS, 43/1.2/0577, 0578, 0579  term treatm. periodic., hostility/suicide ideat.& self harm. report. in   at least 8 hrs(SR Tabs) & 24 hrs (XL Tabs) betw.dos./ dos.reduct.
   719402-001: 37,5 mg, 30, R103,53  childr., seiz.hist., monit.BP of pts.at risk, mania hist., weight loss in   if clinc. indic., elderly, mild ren./liv. impairm./ hepat. cirrhos., dos.
   719403-001: 75 mg, 30, R123,02  already underweight depress.pts., dis./condits.affect. haemodynam.  relat.seiz.risk theref.do not exceed recomm.dos., discont.if hyper-
   719405-001: 150 mg, 30, R209,38  respons./metabol., predisposit.to skin/ muc. membr.bleed., dehydrat.,   sens. reacts.occur, monit.adverse eff.in hepat./ ren.impairm.poss.
   Dosage: Admin.with food at more or less same time each day,   pts.at risk of narr. angle glauc./ rais.IOP  indicat.high meds./ metabolite lev., CV dis., 14 days to elapse betw.
   morn.or even. Swallow whole. Do not divide/crush/chew/ dissolve.  Drug interactions: Sev.reacts.incl.death with init. ther.soon aft.  discont. MAOI & init.ther., do not admin.to pts. with condits.predis-
   Usual recomm.dos: 75 mg once dly. Incr.to 150 mg once dly.aft.sev-  MAOI discont./init.of MAOI ther.soon aft.venlafaxine discont., decr.  pos.to low.seiz. thresh.incl. head trauma hist./seiz.hist./CNS tumour/
   er.wks.if requir. May be incr.furth.in dly.incr.of 75 mg/day to 225 mg.   in AUC & C max.of indinavir, anti-coag.eff.of warfar.incr., decr. clear.&   concom. meds.known to low.seiz.thresh., excess. alcoh./ sedat. use/
   Interv.of 2 wk or more but not less than 4 days betw.dos.increm.   incr.in AUC & C max. of haloperidol but no change in half-life, AUC of   diab.treat.with hypoglycaem./ insul./ stimul.or anorect.prod.use,
   Sev.depress.hospitalis.pts: Dos.may be incr.in increm.of 75 mg   risperidone incr .but total act.moiety pharmacokinet. profile not sig-  discont.& do not re-introduc.if seiz.exper., monit.pts.esp.dur.early
   every 2-3 days to 375 mg once dly. Reduc.dos. grad.accord.to re-  nific.alt., AUC/C max & C min.of desipramine incr.  ther.& dos.chang.for clinic.worsen./suicidal., hist. of suicid.behav./
   spons.& toler.                                             thoughts, young adults, signific.suicid.ideat.prior to commenc.ther.,
   Contraindications: Concom.MAOI’s, insuffic.exper.in childr.  YELATE, Dr Reddy’s [P/S]  consid. chang.therapeut.regim/discont.if psych. sympts.occur which
                                Duloxetine hydrochloride
   und.18 yrs., safety in pregn. & lactat.not est., safety & effic.for treatm.
   beyond one yr.for relapse prevent.not est.  Indications: Depress.as defin.by DSM IV criter., diabet. periph.  are sev./abrupt in onset/not part of pres.sympts., monit.for worsen.
                                                              of depress. sympt.follow.discontin., psych.illn.hist., poss. precipitat.of
                                neuropath.pain (DPNP)
   Side effects: Ecchymos., mucous membr.bleed., prolong.bleed.  (S5) CAPS, 44/1.2/0114, 0115  man.episod.in bipol.disord., screen. adeq.for bi-polar disord.risk, incr.
   time, bld.dyscras., cholester./weight chang., hyponatream., abnorm.  718210-001: 30 mg, 30, R238,30  suicid. think. & behav.assoc.with treatm.of childr.& adolesc. und.18
   liv.funct.tests, hepatit., incr.prolact., SIADH, psych.disords.incl. anx./   718212-001: 60 mg, 30, R238,30  yrs., concom.meds.known to affect cytochrome P450 IIB6 (CYP 2B6)
   depersonalisat./hyperton./paraesthes., dizzin., vertigo, decr.libido,   Dosage: Depress: Init: 60 mg once dly. Effs. observ.with.one wk.but
   trem., trismus, urin. retent./freq., myoclonus, convuls., neurolept.   may take up to 4 wks.  isoenzyme e.g. orphenadrine/ cyclophosphamide, ifosfamide, ticlo-
                                                              pidine & clopidogrel, concom. meds. metabol.by CYP2D6 isoenzyme
   malign./ serotonerg.syndr., extrapyramid.signs, eye disords.incl.my-  Diabet.periph.neuropath.pain: Init.dos: 60 mg once dly.  eg. ß-block/ anti-arrythm./SSRI/TCA’s & antipsychot. should be init.at
   drias., tinnit., card.disords.incl. vasodilat./hypertens./palpit./tachy-  Contraindications: Pregn.& lactat., sev.hepat. impairm., sev.ren.  low.end of their dos.range, incr. dos.may be reqd.with concom.rito-
   card./post. hypotens./QT prolongat./ventric.tachycard./ fibrillat.,   imp.(creatinine clear.&lt;30 ml/ min.), MAOI ther., uncontr.narr.angle   navir but do not exceed recomm.dos., avoid/minim.alcoh., concom.
   oed., migraine, syncope, yawn., dyspn., rhinit., pharyngit., bronchit.,   glauc.or hypertens., adolesc.& childr.und.18 yrs.
   GI disturbs.incl.taste pervers., incr.appet., bruxism, pancreatit., skin   Side effects: Palpitat.& tachycard., vertigo, mydrias., vis./GI dis-  levodopa/amantadine.
                                                              Drug interactions: Incr. desipramine plasma lev., C max & AUC of
   reacts.incl.Stev.-Johns.syndr./erythema multiforme, alopec., sweat.,   turbs., glauc., stomatit., fatig.(incl.asthen.), rigors, feel.abnorm./hot
   myalg., arthralg., rhabdomyolys., imp.urinat., impot., erect.dysfunct.,   & cold, malaise, thirst, hepatit., hepat.fail.with/without jaund., ac.liv.  citalopram incr., drugs known to induc./inhib.metabol.may aff.clinic.
                                                              activ.as bupropion is extens.metabol., reduc.expos.with ritonavir &
   abnorm.orgasm/ejaculat., menorrh., abdom./chest/ neck/back pain,   inj., anaphylact.reacts., weight chang., incr.BP, decr.appet., dehydrat.,   lopinavir, advers.neuropsychiatr. events/ reduc.alcoh.tol.with alcoh.,
   headache, asthen., chills, anaphylax., photosens.react., discont.eff.  hyponatraem., musc.tightn./twitch., akathis., CNS effs., dizzin., head-
   with abrupt withdr.          ache, somnol., tremor, convuls., seroton.syndr., agitat., bruxism, diso-  high.incid.of advers. events with levodopa, elev.BP poss.with nico-
                                                              tine transderm.syst.use.
   Special precautions: Excret.in breast milk, alert dr.to pregn./plan.  rientat., mania, decr.libido, ejaculat./orgasm./urin./ vasc./ sleep dis-
   pregn., suic.risk esp.in depress., observ.for clinic.worsen./suic.esp.  ord., erect.dysfunct., yawn., hyperhidros., night sweats, photosens.,   See also MDR page 376.
   init.& dur.dos. chang., monit.as for psych.& non-psych.disord.pts.,   angioed., skin reacts. incl. Stev.-John.syndr., ecchymos., hot flush.,
   consid. chang.therap.regim./discont.if sev.suicid. impuls.sympts.  orthostat. hypotens., incr.bleed.risk, elev.liv. enzym.
   pres./when such sympts.are abrupt in onset/ not part of pres.sympts.,   Special precautions: Worsen.depress./emerg. suicide ideat./-  1.4.7  Tetracyclic
   grad.withdr.& monit.pt., other concom.meds.with serotonerg. effs.,   behav.risk in maj.depress./other psych./ non-psych disords., monit.
   concom.warfarin, concom.alcoh.not advis., mod.to sev.ren.impairm.,   pts.esp.dur.early ther. & dos.chang. for clinic.worsen./suicid.ideat. /
   mod.hepat.impairm., re-assess longt.treatm.period., hostility/suic.  behav., consid.chang.therapeut.regim/discont.if psych. sympts.occur   ADCO-MIRTERON, AI Pharm Ltd [P/S]
                                                              Mirtazapine
   ideat.& self harm. report.in childr., seiz.hist., discont.in case of seiz.  which are sev./abrupt in onset/ not part of pres.sympts., grad.with-
   developm., allerg.sympt., monit.BP of pts. at risk, mania hist.as acti-  dr.& monit. pts.to minim.withdr.react.risk, concom.CNS act. meds.  Indications: Maj.depress.
                                                              (S5) TABS. A39/1.2/0217, 0218.
   vat.of mania/ hypoman. report., weight loss in already underweight   incl.alcoh., concom.warfar./meds affect. platel. funct., excret.in milk
   depress.pts., toler./dos.escalat., drug abuse hist., concom.syst.illn.,   of lactat.rats, dos.up to 120 mg/day have been used but effic.statist.  708239-001: 15 mg, 30, R274,51
   condits.affect. haemodynam.respons./metabol., underly.condits.   not diff. and advers.event rate high., man./seiz.disord. hist., rais.IOP/   708242-001: 30 mg, 30, R418,12
   poss. comprom.by incr.heart rate, liv.cirrhos., monit. ser.cholester.  pts.at risk of ac.narr.-angle glauc., ren. & hepat. impairm., incr.fast.  Dosage: Cont.ther.x6mnths.for ac.depress.episod.
   dur.longt.use, predispos. bleed. risk, elderly/dehydrat.pts./concom.  bld.sugar & total cholestr.in diab., monit.BP in hypertens.&/ card. dis.   Init: 15 mg/day as sngl.dos.at bedt. which may be grad.incr.accord.
                                pts., substant.alcoh.use, meds.predomin. metabol. by CYP2D6 syst.
                                                              to clinic.respons. Effect. dos. range: 15-45 mg/day. Dos.changes to
   diurets., narr. angl. glauc. risk/rais.IOP, monit.elderly/hepat. dysfunct.
   pts.tak.concom.cimetidine.   Interactions: High.conc.with CYP1A2/ CYP2D6 inhibit., AUC of   be made at interv.of not less than 1-2 wks.
                                meds.metabol.by CYP2D6 incr., concom.meds. highly bound to plasma
   Drug interactions: Sev.reacts.incl.death with init. ther.soon aft.  prot.may incr.free conc.of either med.  Contraindications: Pregn., lactat., childr., concom. MAOI/within 14
   MAOI discont./init.of MAOI ther. soon aft.venlafaxine discont., decr.  days of init/discont. MAOI ther.
   in AUC & C max.of indinavir, anticoag.eff.of warfar.potent., poss.incr.   Side effects: Flu like syndr., asthen., incr.sweat., CNS effs., paraes-
                                                              thes., epilept.seiz., man., convuls., myoclon., restless leg syndr., incr.
   ment./motor skills impairm.with ethanol, decr. clear. & incr.in AUC
   & C max.of haloperidol, first pass metab.inhib.by cimetidine, AUC of   1.4.6   Noradrenaline (and   appet., weight gain, dry mouth, GI disturbs., thirst, bitter taste, oed.,
   risperidone incr., desipramine AUC, C max & C min incr.    periph.oed., orthostat.hypotens., exanthem, jaund., revers.agranulo-
                                                              cytos./ granulocytopen., arthralg., myalg.
   VENLOR XR, Cipla Medpro [P/S]        dopamine) re-uptake   Special precautions: Epilep., hepat./ren. insuffic., card.dis., con-
   Venlafaxine HCl.equiv.to venlafaxine.                      duct.disturbs., ang.pect., recent MI, hypotens., diab.mellit., psychos.,
   Indications: Depress.incl.depress.with anx., prevent. of relapse   inhibitors  bipol. disord.hist., discont.in case of jaund., discont.if sympts.of infect.
   episod.of depress.in pts. respond. to init.6-8 wks.treatm., recurr.  WELLBUTRIN (MDR Listing)  occur & do bld.counts, worsen. depress./emerg.suicid.ideat.& behav.,
   prev.in pts. respond.to 6 mnths relapse prevent., gen. anx. disord.,   monit.pts. caref.dur.early ther.& dos.changes for clinic. worsen./ sui-
   soc.anx.disord.where effectiven.of treatm. not demonstrat.for long.  WELLBUTRIN, (Aspen Pharmacare) GSK [P/S] &  cid.ideat./behav., co-morbid.betw. maj.depress.disord.& other psych./
   than 12 wks.                 Bupropion                     non-psych. disords., consid.chang.therapeut.regim/discont.if psych.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page50.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>&nbsp;&nbsp;&nbsp;<a href="page48.html">48</a>&nbsp;&nbsp;&nbsp;<a href="page49.html">49</a>&nbsp;&nbsp;&nbsp;<a href="page50.html">50</a>&nbsp;&nbsp;&nbsp;<a href="page51.html">51</a>&nbsp;&nbsp;&nbsp;<a href="page52.html">52</a>&nbsp;&nbsp;&nbsp;<a href="page53.html">53</a>&nbsp;&nbsp;&nbsp;<a href="page54.html">54</a>&nbsp;&nbsp;&nbsp;<a href="page55.html">55</a>&nbsp;&nbsp;&nbsp;<a href="page56.html">56</a>
             </td>
             <td width="35%"><a href="page52.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page52.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
